-transparent.png){kind=logo}
New anthracycline antibiotics derived from epsilon-, gamma- and beta-rhodomycinones and epsilon-isorhodomycinone by the microbial glycosidation using an aclacinomycin-negative mutant, the strain KE303, of Streptomyces galilaeus MA144-M1 were studied to elucidate their structures and biological activities. These antibiotics were the products in which the anthracyclinones added as precursors were linked at C-7 or C-10 position with the same trisaccharide moiety (cinerulosyl-2-deoxyfucosyl-rhodosaminyl group) as in the parental antibiotic aclacinomycin A. In addition to antimicrobial activity, they exhibited the growth inhibition of cultured L1210 leukemia cells and the marked inhibition against DNA and RNA synthesis.
Y Matsuzawa, and
A Yoshimoto, and
T Oki, and
H Naganawa, and
T Takeuchi, and
H Umezawa
November 1984,
The Journal of antibiotics,
Y Matsuzawa, and
A Yoshimoto, and
T Oki, and
H Naganawa, and
T Takeuchi, and
H Umezawa
November 1997,
Chemical reviews,
Y Matsuzawa, and
A Yoshimoto, and
T Oki, and
H Naganawa, and
T Takeuchi, and
H Umezawa
August 1984,
The Journal of antibiotics,
Y Matsuzawa, and
A Yoshimoto, and
T Oki, and
H Naganawa, and
T Takeuchi, and
H Umezawa
June 1994,
Microbiology (Reading, England),
Y Matsuzawa, and
A Yoshimoto, and
T Oki, and
H Naganawa, and
T Takeuchi, and
H Umezawa
January 1977,
Folia microbiologica,
Y Matsuzawa, and
A Yoshimoto, and
T Oki, and
H Naganawa, and
T Takeuchi, and
H Umezawa
November 1984,
The Journal of antibiotics,
Y Matsuzawa, and
A Yoshimoto, and
T Oki, and
H Naganawa, and
T Takeuchi, and
H Umezawa
November 1975,
The Journal of antibiotics,
Y Matsuzawa, and
A Yoshimoto, and
T Oki, and
H Naganawa, and
T Takeuchi, and
H Umezawa
August 1993,
The Journal of antibiotics,
Y Matsuzawa, and
A Yoshimoto, and
T Oki, and
H Naganawa, and
T Takeuchi, and
H Umezawa
January 1973,
Folia microbiologica,
Y Matsuzawa, and
A Yoshimoto, and
T Oki, and
H Naganawa, and
T Takeuchi, and
H Umezawa
December 1988,
The Journal of antibiotics,
